Per 0.5 mL dose Attenuated Schwarz measles not <103 CCID50, RIT 4385 mumps (derived from Jeryl Lynn strain) not <103.7 CCID50 & Wistar RA 27/3 rubella virus not <103 CCID50
View Priorix overdosage for action to be taken in the event of an overdose.
Contraindications
Hypersensitivity to neomycin or after previous MMR vaccine administration. Patients w/ severe humoral or cellular (primary or acquired) immunodeficiency eg, symptomatic HIV infection. Pregnancy.
Rare anaphylactic event. Not to be administered intravascularly. Postpone vaccination in subjects suffering from acute severe febrile illness. History of anaphylactic, anaphylactoid, or other immediate reactions subsequent to egg ingestion. History or family history of allergic diseases or convulsions. Syncope. Patients w/ thrombocytopenia. Immunocompromised (eg, asymptomatic HIV subjects); immunocompetent patients. Allow alcohol & other disinfecting agents to evaporate from skin prior to inj. Avoid pregnancy 1 mth after vaccination. Lactation. Infant <12 mth may not respond sufficiently; consider revaccination at or after 12 mth.
Temporary depression of tuberculin skin sensitivity. Administer at different inj sites if to be given at the same time as another injectable vaccine. If cannot be given at the same time as other live attenuated vaccines, an interval of at least 1 mth should be left between both vaccinations. Delay vaccination for at least 3 mth in subjects who have received human γ-globulins or blood transfusion.
Sign Out
